An information criterion for marginal structural models

Statistics in Medicine

Volumn 32, Issue 8, 2013, Pages 1383-1393

  Platt, Robert W ^a   Brookhart, M Alan ^b   Cole, Stephen R ^b   Westreich, Daniel ^b,c   Schisterman, Enrique F ^d  

^a MCGILL UNIVERSITY   (Canada)

^b The University of North Carolina at Chapel Hill   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bias; Causal inference; Marginal structural model; Model specification; Regression analysis

Indexed keywords

ANALYTICAL ERROR; ARTICLE; BREAST FEEDING EDUCATION; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; HEALTH STATISTICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION SYSTEM; MARGINAL STRUCTURAL MODEL; MATHEMATICAL COMPUTING; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SIMULATION; STATISTICAL MODEL; WEIGHT GAIN;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; LIKELIHOOD FUNCTIONS; MALE; MODELS, STATISTICAL;

EID: 84875251309     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5599     Document Type: Article

References (55)

1. Robins JM. Marginal structural models. In 1997 Proceedings of the American Statistical Association, Section on Bayesian Statistical Science, 1998; 1-10.
2. Robins JM. Marginal structural models versus structural nested models as tools for causal inference. In Marginal Structural Models Versus Structural Nested Models as Tools for Causal Inference, Halloran ME, Berry D (eds). Springer: New York, 1999; 95-134.
3. Robins JM. Association, causation and marginal structural models. Synthese 1999; 121:151-179.
4. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560.
5. Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359:1173-1177.
6. Sterne JA, Hernán MA, Ledergerber B, Tilling K, Weber R, Sendi P, Rickenbach M, Robins JM, Egger M. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378-384.
7. MacKenzie EJ, Rivara FP, Jurkovich GJ, Nathens AB, Frey KP, Egleston BL, Salkever DS, Scharfstein DO. A national evaluation of the effect of trauma-center care on mortality. New England Journal of Medicine 2006; 354:366-378.
8. Cotter D, Zhang Y, Thamer M, Kaufman J, Hernan MA. The effect of epoetin dose on hematocrit. Kidney International 2008; 73:347-353.
9. Palella FJ Jr., Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Annals of Internal Medicine 2009; 151:73-84.
10. Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. International Journal of Obesity 2008; 32:S8-14.
11. Cole SR, Frangakis CE. The consistency statement in causal inference: a definition or an assumption? Epidemiology 2009; 20:3-5.
12. VanderWeele TJ. Concerning the consistency assumption in causal inference. Epidemiology 2009; 20:880-883.
13. Mortimer KM, Neugebauer R, van der Laan M, Tager IB. An application of model-fitting procedures for marginal structural models. American Journal of Epidemiology 2005; 162:382-388.
14. Hernan MA, Robins JM. Estimating causal effects from epidemiological data. Journal of Epidemiology and Community Health 2006; 60:578-586.
15. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. American Journal of Epidemiology 2008; 168:656-664.
16. Westreich D, Cole SR. Invited commentary: positivity in practice. American Journal of Epidemiology 2010; 171:674-677.
17. Lefebvre G, Delaney JAC, Platt RW. Impact of mis-specification of the treatment model on estimates from a marginal structural model. Statistics in Medicine 2008; 27:3629-3642.
18. Moodie EE. Risk factor adjustment in marginal structural model estimation of optimal treatment regimes. Biom J 2009; 51:774-788.
19. Harrell FE. Regression Modelling Strategies. Springer-Verlag: New York, NY, 2001.
20. Brookhart MA, van der Laan MJ. A semiparametric model selection criterion with applications to the marginal structural model. Computational Statistics & Data Analysis 2006; 50:475-498.
21. Neugebauer R, Van der Laan M. Nonparametric causal effects based on marginal structural models. Journal of Statistical Planning and Inference 2007; 137:419-434.
22. Hens N, Aerts M, Molenberghs G. Model selection for incomplete and design-based samples. Statistics in Medicine 2006; 25:2502-2520.
23. Cole SR, Hernán MA, Margolick JB, Cohen MH, Robins JM. Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. American Journal of Epidemiology 2005; 162:471-478.
24. Moodie EEM, Platt RW, Kramer MS. Estimating response-maximized decision rules with applications to breastfeeding. Journal of the American Statistical Association 2009; 104:155-165.
25. Hernan MA. A definition of causal effect for epidemiological research. J. Epidemiol. Community Health 2004; 58:265-271.
26. Holland PW. Statistics and causal inference. Journal of the American Statistical Association 1986; 81:945-960.
27. Robins J, Orellana L, Rotnitzky A. Estimation and extrapolation of optimal treatment and testing strategies. Statistics in Medicine 2008; 27:4678-4721.
28. Hernan MA, Lanoy E, Costagliola D, Robins JM. Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin Pharmacol Toxicol 2006; 98:237-242.
29. Cain LE, Robins JM, Lanoy E, Logan R, Costagliola D, Hernán MA. When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. International Journal of Biostatistics 2010; 6.
30. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an aids clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 2000; 56:779-788.
31. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-570.
32. Moodie EE, Delaney JA, Lefebvre G, Platt RW. Missing confounding data in marginal structural models: a comparison of inverse probability weighting and multiple imputation. International Journal of Biostatistics 2008; 4.
33. Akaike H. Information theory and an extension of the maximum likelihood principal. In Information Theory and an Extension of the Maximum Likelihood Principal. Akademia Kiado City, 1973. Editor (eds).
34. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics 2001; 57:120-125.
35. Kramer MS, Guo T, Platt RW, Shapiro S, Collet JP, Chalmers B, Hodnett E, Sevkovskaya Z, Dzikovich I, Vanilovich I. Breastfeeding and infant growth: biology or bias? Pediatrics 2002; 110:343-347.
36. Kramer MS, Chalmers B, Hodnett ED, Sevkovskaya Z, Dzikovich I, Shapiro S, Collet JP, Vanilovich I, Mezen I, Ducruet T, Shishko G, Zubovich V, Mknuik D, Gluchanina E, Dombrovskiy V, Ustinovitch A, Kot T, Bogdanovich N, Ovchinikova L, Helsing E. Promotion of breastfeeding intervention trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA 2001; 285:413-420.
37. Kramer MS, Aboud F, Mironova E, Vanilovich I, Platt RW, Matush L, Igumnov S, Fombonne E, Bogdanovich N, Ducruet T, Collet JP, Chalmers B, Hodnett E, Davidovsky S, Skugarevsky O, Trofimovich O, Kozlova L, Shapiro S. Breastfeeding and child cognitive development: new evidence from a large randomized trial. Arch Gen Psychiatry 2008; 65:578-584.
38. Kramer MS, Fombonne E, Igumnov S, Vanilovich I, Matush L, Mironova E, Bogdanovich N, Tremblay RE, Chalmers B, Zhang X, Platt RW. Effects of prolonged and exclusive breastfeeding on child behavior and maternal adjustment: evidence from a large, randomized trial. Pediatrics 2008; 121:e435-440.
39. Kramer MS, Matush L, Vanilovich I, Platt R, Bogdanovich N, Sevkovskaya Z, Dzikovich I, Shishko G, Mazer B. Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial. BMJ 2007; 335:815.
40. Kramer MS, Matush L, Vanilovich I, Platt RW, Bogdanovich N, Sevkovskaya Z, Dzikovich I, Shishko G, Collet JP, Martin RM, Davey Smith G, Gillman MW, Chalmers B, Hodnett E, Shapiro S. Effects of prolonged and exclusive breastfeeding on child height, weight, adiposity, and blood pressure at age 6.5y: evidence from a large randomized trial. Am J Clin Nutr 2007; 86:1717-1721.
41. Kramer MS, Matush L, Vanilovich I, Platt RW, Bogdanovich N, Sevkovskaya Z, Dzikovich I, Shishko G, Collet JP, Martin RM, Smith GD, Gillman MW, Chalmers B, Hodnett E, Shapiro S. A randomized breast-feeding promotion intervention did not reduce child obesity in Belarus. J Nutr 2009; 139:417S-421S.
42. Kramer MS, Vanilovich I, Matush L, Bogdanovich N, Zhang X, Shishko G, Muller-Bolla M, Platt RW. The effect of prolonged and exclusive breast-feeding on dental caries in early school-age children. New evidence from a large randomized trial. Caries Res 2007; 41:484-488.
43. Platt RW, Schisterman EF, Cole SR. Time-modified confounding. American Journal of Epidemiology 2009; 170:687-694.
44. Tarwater PM, Margolick JB, Jin J, Phair JP, Detels R, Rinaldo C, Giorgi J, Munoz A. Increase and plateau of CD4 T-cell counts in the 3(1/2)years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 27:168-175.
45. Maldonado G, Greenland S. Interpreting model coefficients when the true model form is unknown. Epidemiology 1993; 4:310-318.
46. Van der Laan M, Dudoit S. Unified cross-validation methodology for selection among estimators: finite sample results, asymptotic optimality, and applications. In Unified Cross-Validation Methodology for Selection Among Estimators: Finite Sample Results, Asymptotic Optimality, and Applications. UC Berkeley City, 2003. Editor (ed)(eds).
47. Bang H, Robins JM. Doubly robust estimation in missing data and causal inference models. Biometrics 2005; 61:962-973.
48. Hernan MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, Manson JE, Robins JM. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 2008; 19:766-779.
49. Westreich D, Cole SR, Tien PC, Chmiel JS, Kingsley L, Funk MJ, Anastos K, Jacobson LP. Time scale and adjusted survival curves for marginal structural Cox models. American Journal of Epidemiology 2010; 171:691-700.
50. Box GEP, Cox DR. An analysis of transformations. Journal of the Royal Statistical Society, Series B 1964; 26:211-252.
51. Taylor JMG. The retransformation mean after a power transformation. Journal of the American Statistical Association 1986; 81:114-118.
52. Cox C. The generalized F distribution: an umbrella for parametric survival analysis. Statistics in Medicine 2008; 27:4301-4312.
53. Wei LJ. The accelerated failure time model: a useful alternative to the Cox regression model in survival analysis. Statistics in Medicine 1992; 11:1871-1879.
54. Cole SR, Chu H, Lei N. Nonparametric estimator of relative time with application to the acyclovir prevention trial. Clinical Trials 2009; 6:320-328.
55. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society Series B-Statistical Methodology 1972; 34:187.